Response Genetics, Inc. is engaged in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies. The company was founded by David A. Smith and Kathleen Danenberg on September 23, 1999 and is headquartered in Los Angeles, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
Frequently Asked Questions
What is Market Cap of Response Genetics, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Response Genetics, Inc. market cap is N/A.
What is the 52-week high for Response Genetics, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Response Genetics, Inc. 52 week high is $0.0077 as of September 12, 2025.
What is the 52-week low for Response Genetics, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Response Genetics, Inc. 52 week low is $0.0015 as of September 12, 2025.
What is Response Genetics, Inc. stock price today?
Response Genetics, Inc. stock price today is $0.0033.
What was Response Genetics, Inc. stock price yesterday?
Response Genetics, Inc. stock price yesterday was $0.0024.
What is the PE ratio of Response Genetics, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Response Genetics, Inc.’s P/E ratio is None.
What is the Price-to-Book ratio of Response Genetics, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Response Genetics, Inc. P/B ratio is None.
What is Response Genetics, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Response Genetics, Inc.'s EBITDA is N/A.
What is the 50-day moving average of Response Genetics, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Response Genetics, Inc. 50-day moving average is $0.0024.
How many employess does Response Genetics, Inc. has?
